💰 HCW Biologics Reports Second Quarter 2026 Business
Published by OOPSONLINE.IN · Source: The Manila Times · 1 min read · · Updated
What actually happened
MIRAMAR, Fla., Aug. 14, 2026 (GLOBE NEWSWIRE) -- HCW Biologics Inc. (the 'Company” or 'HCW Biologics”) (NASDAQ: HCWB), a clinical-stage biopharmaceutical company focused on developing transformative fusion immunotherapeutics to treat autoimmune diseases, cancer and senescence-associated dysplasia, today reported financial results and recent business highlights for the three and six months ended June 30, 2026.
Key points
- 14, 2026 (GLOBE NEWSWIRE) -- HCW Biologics Inc.
- (the 'Company” or 'HCW Biologics”) (NASDAQ: HCWB), a clinical-stage biopharmaceutical company focused on developing transformative fusion immunotherapeutics to treat autoimmune diseases, cancer and senescence-associated dysplasia, today reported financial results and recent business highlights for the three and six months ended June 30, 2026.
Summary based on data provided by The Manila Times. Full article available at the original publisher.
- #business
- #biologics
- #reports